there is no such thing as user error
DESCRIPTION
Medical device design necessitates an assessment of risk. The need is prudent given their ecosystem of use, but also mandated by regulatory agencies. Risk management uses analysis protocols to identify and predict situations where a device may fail and assess the consequences. Common techniques, like Failure Mode and Effects Analysis (FMEA) must expand to go beyond engineering and material failure to identify hazard risks due to user-device interactions or “use errors.” During this webinar, we will discuss the practice of the FMEA with added upgrades, such as a Task Analysis and how integration with simulated use labs can help you and your design team be more successful at reducing patient risk.TRANSCRIPT
There is no such thing as User Error
PRESENTER:
Gavin LewManaging Director
User Centric, Inc.
Pamela Stoffregen-GaySr. Marketing Mgr.
User Centric, Inc.
MODERATOR: #uxlunch
@UserCentricInc
Korey JohnsonAssociate Director
User Centric, Inc.
Join the discussion!
2
Company Overview: Snapshot Profile
2
• Founded in 1999; privately held firm with over 50 full time UX research and design consultants
• Most have graduate degrees in psychology, human factors / ergonomics, ethnography, design and human computer interaction
• In 2007, 2008, 2009, 2010, 2011 User Centric was included on the Inc. 5000 List of the fastest growing companies in the U.S.
• UC is arguably the strongest user experience firm in the US
• Healthcare (medical devices and HIT: EHRs)
© 2011 – Proprietary and Confidential
Introduction: In Search of Use Errors
3© April 10, 2023 – Proprietary and Confidential
No One Wants to Make a Device that Causes Errors
4© April 10, 2023 – Proprietary and Confidential
Introduction
Usual Suspects When Use Errors Are Committed
Designers cannot ever think that being “highly trained” solves a medical device that is poorly designed
5© April 10, 2023 – Proprietary and Confidential
Introduction
Increased Vulnerability
While it is true that HCPs are highly educated, often the tasks performed puts them into an “automatic mode” which makes
them more vulnerable to use errors*
6© April 10, 2023 – Proprietary and Confidential
Introduction
* Guenter, et al (2008). Enteral Feeding Misconnections: A Consortium Position Statement, The Joint Commission Journal on Quality and Patient Safety, 34(5): 282-292.
Don’t Forget Other Users…
Originally, pharmacists were not considered to be a relevant user group for use errors, but Flynn, et al. (2003) estimated 51.5 million errors occur per year (4 per day per pharmacy)
Moreover, a human factors-related recall with pharmacists as the user as recent as September 23, 2011
7© April 10, 2023 – Proprietary and Confidential
Introduction
What About Patients?
Especially when a medical device used by HCPs is “repurposed” for use with patients…!
8© April 10, 2023 – Proprietary and Confidential
Introduction
Patients…
9© April 10, 2023 – Proprietary and Confidential
Introduction
Are incredibly diverse – Literacy, education, experience
Receive a wide range of training– Skewed towards no training
Have different perspective and context
Live in varied environments – i.e., uncontrolled environments
– Consider: dogs, younger children
Do research long enough and patients resemble…
A Truly Diverse User Group
10© April 10, 2023 – Proprietary and Confidential
Introduction
Must Users Really Shoulder the Blame?
11© April 10, 2023 – Proprietary and Confidential
Introduction
Definition of a Use Error
Use errors are made by humans and can often be attributed to the design itself
“Use” as opposed to “human error” or “user error” removes blame from the user as the cause of the failure
Targeting design deficiencies of the design itself links remedy to design changes (earlier the better)
Often, we focus on the device itself, but – Interaction with other devices, connections (things) and
– Instructions also contribute to use errors
12© April 10, 2023 – Proprietary and Confidential
Introduction
Focus Towards Improved Risk Management
In an effort to improve patient safety…– The healthcare industry
has focused more attention on risk management tools
– Awareness of the important role that human factors plays in the design process
– By driving more human factors into the design process sooner, rather than later, results in more positive change
13© April 10, 2023 – Proprietary and Confidential
Introduction
What is FMEA?
14© April 10, 2023 – Proprietary and Confidential
FMEA: Failure Modes and Effects Analysis
Answers the simple question: “If a system component fails, what is the effect on system
performance or safety?”
Usage dates back to the 1940’s to evaluate military M&P to identify risks using a bottom-up assessment
As technology advanced into areas, such as space exploration and nuclear power, the need to identify, prioritize and manage risk amplified
At that time, assessment of risk in the design of systems tended to involve engineering and material failure.
15© April 10, 2023 – Proprietary and Confidential
What is FMEA?
Engineers: Two types of FMEA Risk Analyses
1. DESIGN FMEA. A design FMEA is used to examine the components of a product to identify potential failures. – For example, in the automotive industry, a design FMEA is
conducted on all components and subsystems of a new car during the design and manufacturing phases.
– The FMEA tool is used to evaluate the correctness of the materials, accuracy of specifications, and all other elements of design required to make a safe automobile.
2. PROCESS FMEA. A process FMEA is used to analyze the processes used to make a product.
16© April 10, 2023 – Proprietary and Confidential
What is FMEA?
Wait — Where is the User in the FMEA?
17© April 10, 2023 – Proprietary and Confidential
What is FMEA?
Need to Focus on the User in the FMEA
18© April 10, 2023 – Proprietary and Confidential
How to…
“If a system component fails, what is the effect on system performance or safety?”
Severity of Harm (S)
Probability (P)
(S x P)
“If a user commits an error, what is the effect
on system performance or safety?”
How to Conduct an FMEA
19© April 10, 2023 – Proprietary and Confidential
Towards a More “Use–Error Focused-–FMEA”
Expanding upon a chapter entitled “Risk management in medical products” by Ed Israelski and Bill Muto In Pascale Carayon’s recently published textbook, Handbook of
Human Factors and Ergonomics in Health Care and Patient Safety, Second Edition
Ed and Bill describe a step-by-step process to identify hazards and integrate it into the medical product development process
They advocate one major addition to the FMEA procedure which adds the user into the process
– Perform a Task Analysis as this can predict user behaviors that relate to design interaction
20© April 10, 2023 – Proprietary and Confidential
How to…
But First, Here is an Example FMEA
FMEA appears in many different styles Ultimately, it is really a worksheet (table) Used by the team to document and work through issues Often has color to pull attention to specific rows
21© April 10, 2023 – Proprietary and Confidential
How to…
12-Step Process (Israelski & Muto, 2012)
1. Form a Team
2. Perform a Task Analysis
3. Start a Worksheet
4. Brainstorm Potential Use Errors (failure modes)
5. List potential Effects of each Failure Mode / operator error
6. Assign Severity ratings (S)
7. Estimate the Probability of occurrence ratings (P)
8. Derive a Risk Index (S x P)
9. Prioritize Risks by risk index values
10. Take Actions to eliminate or reduce the high priority failure modes
11. Estimate Effectiveness of action ratings
12. Revise the Risk Priorities
22© April 10, 2023 – Proprietary and Confidential
How to…
Israelski, E., & Muto. W. (2012). Risk management in medical products. In P. Carayon (Ed.), Handbook of Human Factors and Ergonomics in Health Care and Patient Safety, Second Edition. CRC Press.
Step 1: Form a Team
Team composition includes representatives from:– Product team
– Regulatory
– Human Factors
– Engineering (Development)
– Medical Affairs
– Quality Assurance
– Training
– User Group representatives
Agree upon goals and procedures to conduct the FMEA
23© April 10, 2023 – Proprietary and Confidential
How to…
Step 2: Conduct a Task Analysis
Conduct a formal task analysis
Don’t get lured into “we’ll do the task analysis AND brainstorm”
Provide team with tasks, user profiles, use environment, and examples of use errors
24© April 10, 2023 – Proprietary and Confidential
How to…
Back toEntryPoint
User may be first-time or repeat visitorUser is just browsing for information on upcoming events "I want to see what's coming soon"
Just Browsingfor Info by:- Act- Venue- Date- Genre- Geographic Area- Upcoming Events
Back toEntryPoint
Just-browsing...Seeing what's available...
Browse by Name(Event / Venue)
Browsing by Genre Browsing by Date Browse by Deals
Search by Name
Show GenreShow me what's coming up
this weekendShow me latest deals
Show search resultsList of Acts: MetroList of Venues: Metroe.g., Amazon.com
TixAvail?
TM.com should offer help- Email new dates- Avail tickets- Next Concert- etc.
Anythinginteresting?
TM.com should help- Try another venue?- List headliners
Go toBuy
"What'splaying at theMetro?"
"What dealsare available?"
"What isavailable thisweekend?"
"What wouldbe fun to dowith thefamily?"
Show List of Events
Select Act orVenue
SelectPerformance
Yes
No
ExitTicketmaster.com
No
Yes
Depression
Try to limit browseto 3-4 steps
Select Genre
Select sub-categories
Show sub-category lisitng
Search by full listing?AlphaNumeric Jum
Jump to Date
Sort by VenueSort by State
Sort by State
Closest to Zip
Search by Price
Show List of Acts
Search by full listing?
AlphaNumeric Jump
ShowEvents
ShowEvents
ShowEvents
Search by DatePromo on Home
Link to Promos
Show Genre
Select Promo
ShowEvents
Save “brainstorming” for identifying use errors
Step 3: Start a Worksheet
Settle on the format and columns
Consider using large sheets of paper (11” x 17” or larger) with gridlines
Documenting electronically via MS Excel and projecting screen to a wall can facilitate group interactions and discussions
25© April 10, 2023 – Proprietary and Confidential
How to…
Step 4: Brainstorm Potential Use Errors (Failure Modes)
Follow typical brainstorming rules (i.e., facilitate ideation over debate over merit discussions)
Recognize efficiencies of breaking into sub-groups to reduce “tangent takeover”
Actually helps to have the device (sounds silly…) Use data from customer complaints or MDRs
26© April 10, 2023 – Proprietary and Confidential
How to…
Step 5: List Potential Effects of Each Failure Mode
For each use error, describe the potential harm resulting from the Potential Effect
When multiple harms can occur– List harms and elevate worst-case scenarios to the top, so
they can be addressed first
27© April 10, 2023 – Proprietary and Confidential
How to…
Step 6: Assign Severity Ratings (S)
Assign a quantitative level of the Severity of the Harm Various levels of (S) are often used
28© April 10, 2023 – Proprietary and Confidential
How to…
Example of a Five-level Severity Scale (S)
Three-level Severity Scale– “Severe, Moderate, Negligible”
29© April 10, 2023 – Proprietary and Confidential
Methodology
Step 7: Estimate the Probability of Occurrence Ratings (P)
Assign a quantitative level of the Probability of the use error occurring
Various levels of (P) are often used
30© April 10, 2023 – Proprietary and Confidential
How to…
Step 7: Estimate the Probability of Occurrence Ratings (P)
(P) levels can be 3 or 10 point scales derived from:– Historical data, prediction of probabilities using analytical
or simulation techniques, experimental data, and even expert judgment.
31© April 10, 2023 – Proprietary and Confidential
Methodology
Step 7: Estimate the Probability of Occurrence Ratings (P)
Consider that this (P) encompass situations and circumstances, as well as, an entire sequence of events from the occurrence of the initiating cause through to the occurrence of harm– Does the hazardous situation occur in the absence of a
failure?
– Does the hazardous situation occur in a fault condition?
– Does the hazardous situation occur only in a multiple-fault condition?
– How likely is it that a hazardous situation will lead to harm?
– The likelihood that a hazardous situation will lead to harm is influenced by the life-cycle of the medical device and estimated number of devices in the market
32© April 10, 2023 – Proprietary and Confidential
Methodology
Step 8: Derive a Risk Index (S x P)
Risk Level = Severity x Probability Forms a Risk Priority Number (RPN) Compare to a Risk Evaluation Matrix
33© April 10, 2023 – Proprietary and Confidential
How to…
Risk Evaluation Matrix
34© April 10, 2023 – Proprietary and Confidential
Methodology
Regulators require special attention be paid to all catastrophic harm severities regardless of (P) – Historically, too many manufacturers have low balled (P)
Step 9: Prioritize the Risks by Risk Index Values
Sort by Risk Index Level Consider Risk Control Measures
– Failure modes that can be addressed immediately
– Failure modes that require
no action
35© April 10, 2023 – Proprietary and Confidential
How to…
Step 10: Take Action to Eliminate or Reduce Risk
Talking point:
36© April 10, 2023 – Proprietary and Confidential
How to…
Really Cool Opening Scene in a Nuclear Missile Silo
37© April 10, 2023 – Proprietary and Confidential
Introduction
West Wing star was more skeptical when a message came through and was hesitant to turn his key…
Forcing the Reservoir Dogs Star to Suggest He Comply
38© April 10, 2023 – Proprietary and Confidential
Introduction
“Turn your key, sir!”
Potentially Dangerous Actions Should Require More Effort
This is where design can play a role to mitigate use errors and improve patient safety
Many medical device manufacturers mitigate risk based on the ALARP (As Low As Reasonably Practicable) – Accepts that there is a practical limit to the time, effort, and
money that can be spent trying to drive a risk to zero Still, manufacturers must justify
– Burden is to show that cost required to reduce the tolerable risk further would be grossly disproportionate to the benefit gained and risks are those that are improbable and marginally severe thereby requiring no further mitigation
Make it hard for users to do something wrong
and easier for them to do it right
39© April 10, 2023 – Proprietary and Confidential
Introduction
Step 11: Estimate the Effectiveness of Actions
Did the Risk Control Measure make the device safer by:– Eliminating the particular hazard?
– Reducing the Severity (S) and/or Probability (P)?
– Adding protective measures, such as safeties or alarms?
– Providing warning labels and instructions?
Step 12: Revise Risk Priority (Risk Acceptability)
40© April 10, 2023 – Proprietary and Confidential
How to…
ISO 14971:2007 Annex Updates
Taking FMEA a Step Further…
41© April 10, 2023 – Proprietary and Confidential
Addendum to the 12 Steps…
This paper seeks to evolve the process and take it to the next level
The critical outcome of the FMEA with a Task Analysis is a list of potential use errors However, these potential use errors are limited to
what can be ideated in the brainstorming activity All too often, these brainstorming activities occur in a
closed office environment or even worse, sometimes conducted without the device!
42© April 10, 2023 – Proprietary and Confidential
A Step Further…
Where Does Brainstorming Occur?
43© April 10, 2023 – Proprietary and Confidential
A Step Further…
Review FMEA in a Simulated Environment
44© April 10, 2023 – Proprietary and Confidential
A Step Further…
Review FMEA in a Simulated Environment
45© April 10, 2023 – Proprietary and Confidential
A Step Further…
Break Out When Necessary
46© April 10, 2023 – Proprietary and Confidential
A Step Further…
Should a set of use errors be uncovered…– Break off sub-team to explore the new line of errors while
the main team will continue down the list
Takeaways
An FMEA process combined with Task Analysis improves risk management
Addition of simulated environments can increase the number of identified use errors and precision
The goal is not to box the answer correctly the first time, but to get smarter all through the research process– FMEA should continue to evolve from exploratory to
validation testing
47© April 10, 2023 – Proprietary and Confidential
A Step Further…
References
ISO 14971:2007 (with special emphasis on Annex D and E) Flynn, E.A., Barker, K.N., & Carnahan, N.J. (2003). National Observational
Study of Prescription Dispensing: Methods, J Am Pharm Assoc. 43(2): 191-200.
Guenter, P., Hicks, R.W., Simmons, D., Crowley, J., Joseph, S., Croteau, R., Gosnell, C., Pratt, N.G., & Vanderveen, T.W. (2008). Enteral Feeding Misconnections: A Consortium Position Statement, The Joint Commission Journal on Quality and Patient Safety, 34(5): 282-292.
Israelski, E., & Muto. W. (2012). Risk management in medical products. In P. Carayon (Ed.), Handbook of Human Factors and Ergonomics in Health Care and Patient Safety, Second Edition. CRC Press.
Kaye, R,, & Crowley, J. (2000). Medical device use-safety: Incorporating human factors engineering into risk management. Food and Drug Administration
Logan, M.K. (2010). A roundtable discussion: Increased focus on human factors drives device safety improvements. Human Factors Horizons. 8-15
48© April 10, 2023 – Proprietary and Confidential
49
PRESENTER:
Gavin LewManaging Director
User Centric, Inc.
#uxlunch
@UserCentricInc
Korey JohnsonAssociate Director
User Centric, Inc.
Join the discussion!
Up next:Conducting Longitudinal Mobile StudiesTuesday, Aug 21, 12:00 PM CDTwww.usercentric.com/webinars
Questions?Questions?